8401 - 8425 of 8587 Results
Title
Year
-
OPENTitle: Study protocol for the Heads-Up trial: a phase II randomized controlled trial investigating head-up tilt sleeping to alleviate orthostatic intolerance in Parkinson’s Disease and parkinsonismJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-023-03506-xBest OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-023-03506-xCitation Count: 1
-
OPENTitle: Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 InhibitorJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 6Issue #: 5Start Page: 584End Page: 589Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.5b00064Best OA location URL: http://doi.org/10.1021/acsmedchemlett.5b00064Citation Count: 50
-
OPENTitle: Biallelic NDUFA13 variants lead to a neurodevelopmental phenotype with gradual neurological impairmentJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae453Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae453/61218229/fcae453.pdfCitation Count: 2
- Impulse control disorder in Parkinson’s disease is associated with abnormal frontal value signalling2023OPENTitle: Impulse control disorder in Parkinson’s disease is associated with abnormal frontal value signallingJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 9Start Page: 3676End Page: 3689Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awad162Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad162/50350389/awad162.pdfCitation Count: 13
-
OPENTitle: Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2016.00271Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2016.00271/pdfCitation Count: 7
-
RESTRICTEDTitle: Structure–Functional Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward the Discovery of Biased Dopamine D1 Receptor AgonistsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 12Start Page: 1818End Page: 1831Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00235Citation Count: 3
-
RESTRICTEDTitle: Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetinJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 1816End Page: 1826Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2013.04.010Citation Count: 80
-
OPENTitle: The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 163End Page: 169Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.027Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/111216027/The_role_of_phosphodiesterase_WILSON_Accepted18February2019_GREEN_AAM.pdfCitation Count: 15
-
OPENTitle: Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique StudyJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/2381468320978407Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/2381468320978407Citation Count: 22
-
OPENTitle: New Developments in Cholinergic Imaging in Alzheimer and Lewy Body DisordersJournal Name: Current Behavioral Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 4Start Page: 278End Page: 286Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s40473-020-00221-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7992054Citation Count: 8
-
OPENTitle: Tandem Ring Opening/Intramolecular [2 + 2] Cycloaddition Reaction for the Synthesis of Cyclobutane Fused Thiazolino-2-PyridonesJournal Name: The Journal of Organic ChemistryPublisher: American Chemical Society (ACS)Vol: 86Issue #: 23Start Page: 16582End Page: 16592Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.joc.1c01875Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.joc.1c01875Citation Count: 2
-
OPENTitle: MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson’s HLA locus exhibits epigenetic regulationJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-025-95679-3Best OA location URL: https://www.nature.com/articles/s41598-025-95679-3.pdfCitation Count: 0
- A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults2025OPENTitle: A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adultsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251356503Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1877718X251356503Citation Count: 0
-
RESTRICTEDTitle: A deep 1-D CNN learning approach with data augmentation for classification of Parkinson’s disease and scans without evidence of dopamine deficit (SWEDD)Journal Name: Biomedical Signal Processing and ControlPublisher: Elsevier BVVol: 91Issue #:Start Page: 106008End Page: 106008Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bspc.2024.106008Citation Count: 8
-
RESTRICTEDTitle: Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine LearningJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2144End Page: 2155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28631Citation Count: 60
- Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology2021OPENTitle: Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathologyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 3Start Page: 1001End Page: 1017Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab374Best OA location URL: https://academic.oup.com/brain/article-pdf/145/3/1001/43500027/awab374.pdfCitation Count: 20
-
RESTRICTEDTitle: Association of liver fibrosis with cognitive decline in Parkinson’s diseaseJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 119Issue #:Start Page: 10End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2023.11.019Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11198872Citation Count: 5
-
OPENTitle: LRP1: a novel receptor for the transmission of pathological α-SynucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00582-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-022-00582-4Citation Count: 1
-
OPENTitle: Profiling Protein–Protein Interactions in the Human Brain by Refined Cofractionation Mass SpectrometryJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 23Issue #: 4Start Page: 1221End Page: 1231Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.3c00685Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11065482Citation Count: 1
-
RESTRICTEDTitle: Acoustic Analysis of Intonation in Persons With Parkinson's Disease Receiving Transcranial Magnetic Stimulation and Intensive Voice TreatmentJournal Name: Journal of VoicePublisher: Elsevier BVVol: 37Issue #: 2Start Page: 203End Page: 214Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jvoice.2020.12.019Citation Count: 8
-
OPENTitle: LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neuronsJournal Name: AutophagyPublisher: Informa UK LimitedVol: 18Issue #: 5Start Page: 1020End Page: 1048Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/15548627.2021.1967615Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2021.1967615?needAccess=trueCitation Count: 41
-
RESTRICTEDTitle: Apolipoprotein E Genotype Contributes to Motor Progression in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 196End Page: 200Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28805Citation Count: 27
-
RESTRICTEDTitle: Highly sensitive HPLC-MS/MS assay for the quantitation of ondansetron in rat plasma and rat brain tissue homogenate following administration of a very low subcutaneous doseJournal Name: Journal of Pharmaceutical and Biomedical AnalysisPublisher: Elsevier BVVol: 175Issue #:Start Page: 112766End Page: 112766Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jpba.2019.07.014Citation Count: 11
-
OPENTitle: TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiencyJournal Name: Annals of NeurologyPublisher: WileyVol: 74Issue #: 6Start Page: 837End Page: 847Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/ana.23999Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.23999Citation Count: 80
-
OPENTitle: Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s diseaseJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 213Issue #: 9Start Page: 1759End Page: 1778Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1084/jem.20160368Citation Count: 348